From our lists 38 new startups in Sweden worth knowing (2026) and 30 new startups in Stockholm worth knowing (2026)
RevvoMed maps the membrane proteins on the surface of cells in diseased and healthy tissue to find drug targets that current methods overlook, starting with cancer, and plans to turn validated targets into patent-protected drug assets that it licenses, sells or develops with pharmaceutical companies. Founded in 2025, according to Swedish Tech News, it is led by CEO Nina Schiller, Executive Chairman Christian Schiller and CSO Robin Löving, who spent more than ten years as CSO at Salipro Biotech. On 10 November 2026 it announced that it had started operations in Stockholm after a 7 million kronor pre-seed round led by entrepreneurs Johan Staël von Holstein and Erik Wikström. Website: revvomed.com. Source: RevvoMed, Swedish Tech News.
Questions about RevvoMed
What does RevvoMed do?
RevvoMed: finding new cancer drug targets on the surface of cells.
Where is RevvoMed based?
RevvoMed is based in Stockholm, Sweden.
Where can I read more about RevvoMed?
RevvoMed is in our list 38 new startups in Sweden worth knowing (2026): https://meetnewbrands.com/articles/new-startups-in-sweden-2026